top of page


We are currently evaluating the immunogenicity and efficacy of Hiltonol® (PICLC) alone, with vaccines or with immune costimulators over a variety of indications in Phase I and II clinical trials.  (See for a complete list)

chart (5).png

Hiltonol® Collaborative Clinical Trials by Indication (see for a complete list)

chart (3).png

# of Phase I/II Clinical Trials

bottom of page